Lawsuits for Community and Occupational Exposure to Ethylene Oxide Lawsuits concerning ethylene oxide (EtO) exposure have been filed by both community residents and workers who allege serious health issues, including various cancers, due to prolonged exposure to EtO emissions from sterilization facilities
Tirzepatide is a GIP and GLP-1 receptor agonist used for chronic weight management with lifestyle changes in adults with a BMI of: 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) with comorbidities such as hypertension, diabetes, dyslipidemia, sleep apnea, or cardiovascular disease
Community research planning today is mostly subcutaneous and uses much lower doses based on tolerability rather than nmol/kg targets
Nearly a year ago, the condition worsened
Gut microbiota metabolism of L-carnitine and cardiovascular risk